Skip to main content
Premium Trial:

Request an Annual Quote

Gulf Coast Chemical Genomics Consortium to Use Invitrogen siRNA Screening Tech for Disease Studies

NEW YORK (GenomeWeb News) - A consortium of Texas research institutions studying genomics and disease will use Invitrogen’s siRNA library and screening tools to study cancer, diabetes, and metabolic disorders, the company said today.
Researchers at six locations, including the University of Texas at Houston and at Galveston, Baylor College, M.D. Anderson Cancer Center, and Rice University, will use Invitrogen’s human kinase and human and mouse nuclear receptor collections in high-throughput image-based screening and gene expression experimental research.
The consortium, known as the Gulf Coast Consortium for Chemical Genomics, will use Invitrogen’s SYBR GreenER qPCR technology, and its Molecular Probes image tools to measure various effects on siRNA molecules.
Financial terms of the agreement were not released.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.